Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Carcinoma, Hepatocellular 8Hepatitis B, Chronic 4Fibrosis 3Hepatitis B 2Recurrence 1Liver Cirrhosis 1Hepatitis D 1Esophageal and Gastric Varices 1

Interventions

Tenofovir 4entecavir 3peginterferon alfa-2b 2peginterferon alfa-2a 1durvalumab 1babao dan 1Radiofrequency Ablation 1Observation 1Nucleosides 1Methods 1Interferons 1Cholecalciferol 1Acids 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Hepatitis B, Chronic × Tenofovir × Gastrointestinal × Clear all
NCT02224456 2022-02-14

Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis

GlaxoSmithKline

Phase 4 Completed
197 enrolled 27 charts
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Hepatitis B, Chronic

NCT02129829 2020-09-28

WATCH

Imperial College London

Completed
1,079 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Hepatitis B, Chronic

NCT04160897 2019-11-13

Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis

Ruijin Hospital

Unknown
4,000 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis B, Chronic

NCT01872988 2014-09-04

Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma

Taichung Veterans General Hospital

Phase 3 Terminated
320 enrolled
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular, Hepatitis B, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡